| Value | ₹0.30 Cr |
|---|
BSE filing, NSE: MAYUKH. Summary written from the filing by ALFA Finder's alert engine.
Sattva Sukun Lifecare Ltd: key numbers
- Share price
- ₹1.16
- Market cap
- ₹44.50 Cr
- Revenue (annual)
- ₹32.25 Cr
- Net profit (annual)
- ₹0.11 Cr
- P/E (TTM)
- -91.9×Sector 43.1×
- Promoter holding
- 3.65%-2.74% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sattva Sukun Lifecare Ltd
All →Sattva Sukun Lifecare Other Announcement
Tavexia Lifecare Ltd submitted its quarterly shareholding pattern report for the period ended September 30, 2026, in compliance with SEBI regulations.
Sattva Sukun Lifecare Acquisition Worth ₹67.19 Cr
Tavexia Lifecare will acquire a 60% stake in Meyonex Pharmaceuticals Limited for ₹67.19 Crore. This strategic investment aims to expand its pharmaceutical sector presence.
- Value
- ₹67.19 Cr
Sattva Sukun Lifecare Annual General Meeting
Tavexia Lifecare Limited concluded its 46th Annual General Meeting on September 30, 2026. Shareholders approved the financial statements, auditor appointment, related party transactions, and director re-appointment.
Sattva Sukun Lifecare Promoter Selling: ₹0.03 Cr
Promoter group entity Roshan Dealmark Private Limited sold 2,50,000 equity shares of Tavexia Lifecare Ltd via market sale.
- Value
- ₹0.03 Cr
- Promoter stake change
- -0.04%
Sattva Sukun Lifecare Board Meeting Date
Tavexia Lifecare will hold a board meeting on October 7, 2026, to discuss the proposed acquisition of Meyonex Pharmaceuticals and approve the half-yearly financial results.
Sattva Sukun Lifecare Promoter Selling: ₹0.08 Cr
Roshan Dealmark Private Limited (Promoter Group) sold 700,000 equity shares of Tavexia Lifecare Ltd via market sale on September 25, 2026.
- Value
- ₹0.08 Cr
- Promoter stake change
- -0.18%
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.